Participant retention in paediatric randomised controlled trials published in six major journals 2015-2019:

Daisy M Gaunt1, Cat Papastavrou Brooks2, Hugo Pedder2

  • 1Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. daisy.gaunt@bristol.ac.uk.

Trials
|June 14, 2023
PubMed

Insights

Participant retention in paediatric randomized controlled trials (RCTs) is crucial. Factors like frequent follow-ups, shorter trial durations, and engagement methods significantly improve retention in pediatric research.

Area of Science:

  • Clinical Trials
  • Pediatric Research
  • Health Services Research

Background:

  • Participant retention in pediatric randomized controlled trials (RCTs) is under-researched.
  • Challenges include child development, multiple participants, and proxy reporting.
  • This review explores factors influencing retention in pediatric trials.

Approach:

  • Systematic review and meta-analysis of pediatric RCTs published 2015-2019.
  • Data extracted on context and design factors influencing retention.
  • Univariate random-effects meta-regression analysis used to determine associations.

Key Points:

  • Higher retention observed with ≥5 follow-ups, <6 months between randomization and outcome, and inactive data collection.
  • Trials with older children (≥11 years) and without additional participants showed better retention.
  • Active/placebo controls and engagement methods positively impacted retention.

Conclusions:

  • Paediatric RCTs rarely report modifiable factors that enhance retention.
  • Multiple, regular pre-outcome follow-ups and outcomes within 6 months may reduce attrition.
  • Qualitative research and engagement strategies are recommended for improving retention in pediatric trials.
Abstract

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
166
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K